Overview
Status
Active
Registry date
2018-06-29
Registered address
ul. Postępu 15C, 02-676 Warszawa, Poland
Electronic delivery address
AE:PL-55630-64919-BHBHJ-22
Financials
Revenue history (in m)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 464 days for 2023).
- 2025not filed
- 202423/10/2025
- 202322/10/2025
- 202221/09/2023
- 202121/09/2023
- 202024/11/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 24.40mMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 329.23kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 23.60mMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 7.45mMedianUSD 609.79kAverageUSD 11.85m
Industry
Authorized Representatives
Frank Schmalbach – Management Board Member
Manner of representation
Each member of the management board represents the company independently.
Beneficial owners
No beneficial owners recorded for the branch Kedrion Biopharma Gmbh.
Foreign Company
Name or business name of the foreign company
KEDRION BIOPHARMA GESELLSCHAFT MIT BESCHRANKTER HAFTUNG GESELLSCHAFT MIT BESCHRANKTER HAFTUNG
Headquarters address of the foreign company
BAHNHOFSTRASSE 96, 82166 GRAEFELFING, NIEMCY
Register storing the foreign company's records
HANDELSREGISTER, , AMTSGERITCHTS MUNCHEN
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Orkla CareS.A. | $43,777,691.06 | orklacare.com.pl | ||
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| PromedS.A. | $12,643,674.56 | promed.com.pl | ||
| AO East Europesp. z o.o. | $12,156,227.53 | aoeasteurope.pl | ||
| MassmedicaS.A. | $8,216,274.00 | massmedica.com | ||
| SPA Landsp. z o.o. | $4,782,973.66 | hydrafacial.pl | ||
| Hair Partnerssp. z o.o. | $4,347,484.74 | hairpartners.pl | ||
| Balmed Polandsp. z o.o. | $3,140,735.80 | balmed.it |
Change history
| Date | Event | |
|---|---|---|
| 2024-12-11 | Address change (Ul. Ostrobramska 75c, 04-175, Warszawa → Ul. Postępu 15c, 02-676, Warszawa) | |
| 2021-09-17 | Name change (Kedrion International Gmbh (spółka Z Ograniczoną Odpowiedzialnością) Oddział W Polsce → Kedrion Biopharma Gmbh (spółka Z Ograniczoną Odpowiedzialnością) Oddział W Polsce) | |
| 2018-06-29 | Entered in the register |
FAQ
The main business activity of Kedrion Biopharma Gmbh focuses on wholesale of pharmaceutical goods.
The business was registered in the Polish National Court Register (KRS) on June 29, 2018.
The headquarters is located at: ul. Postępu 15C, 02-676 Warszawa.
The legal form of this entity is a branch of a foreign entrepreneur.
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the business generated total revenue of $24,395,089, representing a decrease of 15.2% compared to 2023.
Yes, in 2024 the business was profitable, achieving a net profit of $329,230, meaning the business increased its profit by 22.9%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $22,366,448 in 2024, representing 95% of all operating expenses.
Last updated: 2026-03-29